Old Web
English
Sign In
Acemap
>
authorDetail
>
James Vu
James Vu
Tulane University
Medicine
Pathology
Germline
Castrate-resistant prostate cancer
Cancer research
5
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Gastroduodenal artery steal syndrome treated with coil embolization after orthotopic liver transplantation
2021
James Vu
Jesus Beltran-Perez
Bruce Bordlee
Show All
Source
Cite
Save
Citations (0)
Evaluation of circulating tumor DNA (ctDNA) with respect to germline alterations in metastatic castrate resistant prostate cancer patients.
2019
Journal of Clinical Oncology
Peter Steinwald
Lynne Chapman
Bryce Raymon Christensen
Leta Ko
James Vu
Joshua Schiff
Lahiru Ranasinghe
Marcus Marie Moses
Patrick Cotogno
Charlotte Manogue
Jodi Lyn Layton
Brian E. Lewis
A. Oliver Sartor
Elisa Ledet
Show All
Source
Cite
Save
Citations (0)
DNA repair germline pathogenic mutation associations with treatment duration and family history in prostate cancer.
2019
Journal of Clinical Oncology
James Vu
Marcus Marie Moses
Lahiru Ranasinghe
Patrick Cotogno
Charlotte Manogue
Brian E. Lewis
Jodi Lyn Layton
A. Oliver Sartor
Elisa Ledet
Show All
Source
Cite
Save
Citations (0)
Aberrations in androgen receptor ctDNA varies by race in metastatic castrate-resistant prostate cancer.
2019
Journal of Clinical Oncology
Bryce Raymon Christensen
Elisa Ledet
James Vu
Peter Steinwald
Lynne Chapman
Leta Ko
Lahiru Ranasinghe
Joshua Schiff
Marcus Marie Moses
Patrick Cotogno
Charlotte Manogue
Brian E. Lewis
Jodi Lyn Layton
A. Oliver Sartor
Show All
Source
Cite
Save
Citations (0)
Germline DNA repair mutations in men with prostate cancer are less frequent in African Americans as compared with Caucasians.
2019
Journal of Clinical Oncology
Piper L.W. Nicolosi
Elisa Ledet
Shan Yang
Scott T. Michalski
James Vu
A. Oliver Sartor
Show All
Source
Cite
Save
Citations (1)
1